5026 - 5050 of 8808 Results
Title
Year
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
RESTRICTEDTitle: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034Citation Count: 13
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
RESTRICTEDTitle: Serum neurofilament light chain predicts future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 102End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.015Citation Count: 8
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Citation Count: 17
-
RESTRICTEDTitle: Coincident parkinsonism and myasthenia gravis: A case seriesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 4End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.016Citation Count: 7
-
OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 49
-
RESTRICTEDTitle: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System AtrophyJournal Name: NeurosciencePublisher: Elsevier BVVol: 459Issue #:Start Page: 142End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003Citation Count: 4
-
RESTRICTEDTitle: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat ModelJournal Name: NeurosciencePublisher: Elsevier BVVol: 460Issue #:Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019Citation Count: 6
-
RESTRICTEDTitle: Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 105Issue #:Start Page: 378.e1End Page: 378.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.04.011Citation Count: 14
-
OPENTitle: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammationJournal Name: Mucosal ImmunologyPublisher: Elsevier BVVol: 14Issue #: 3Start Page: 652End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7Best OA location URL: https://www.nature.com/articles/s41385-020-00354-7.pdfCitation Count: 34
-
RESTRICTEDTitle: Disease course and treatment patterns in progressive supranuclear palsy: A real-world studyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 421Issue #:Start Page: 117293End Page: 117293Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117293Citation Count: 15
-
OPENTitle: Detect and correct bias in multi-site neuroimaging datasetsJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 67Issue #:Start Page: 101879End Page: 101879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.media.2020.101879Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1361841520302437?via%3DihubCitation Count: 99
-
OPENTitle: Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulationJournal Name: Journal of Vascular SurgeryPublisher: Elsevier BVVol: 75Issue #: 1Start Page: 223End Page: 228Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jvs.2021.07.238Best OA location URL: http://www.jvascsurg.org/article/S0741521421019819/pdfCitation Count: 10
-
OPENTitle: Are hedge funds' charitable donations strategic?Journal Name: Journal of Corporate FinancePublisher: Elsevier BVVol: 66Issue #:Start Page: 101842End Page: 101842Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcorpfin.2020.101842Citation Count: 12
- Classification of Parkinson's disease based on multi-modal features and stacking ensemble learning2020RESTRICTEDTitle: Classification of Parkinson's disease based on multi-modal features and stacking ensemble learningJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 350Issue #:Start Page: 109019End Page: 109019Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.109019Citation Count: 61
-
RESTRICTEDTitle: Parkinson’s Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype? (S32.005)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 104Issue #: 7_Supplement_1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000212426Citation Count: 0
-
OPENTitle: Exploring the intersection between orthostatic hypotension and daytime sleepiness in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 468Issue #:Start Page: 123366End Page: 123366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2024.123366Citation Count: 4
-
OPENTitle: Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease (4738)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4738Citation Count: 6
-
RESTRICTEDTitle: Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequencesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.060159Citation Count: 1
-
OPENTitle: Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA levelJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.055041Best OA location URL: https://doi.org/10.1101/2021.04.05.438450Citation Count: 4
-
OPENTitle: Smaller Total and Subregional Cerebellar Volumes in Posttraumatic Stress Disorder: A Mega-Analysis by the ENIGMA-PGC PTSD WorkgroupJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 93Issue #: 9Start Page: S44End Page: S44Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2023.02.123Best OA location URL: https://doi.org/10.1101/2022.10.13.512111Citation Count: 3